Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s share price traded down 15% on Wednesday . The stock traded as low as $1.36 and last traded at $1.36. 560 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 6,849 shares. The stock had previously closed at $1.60.
Nutriband Stock Down 15.0%
The firm’s 50 day moving average price is $1.99 and its two-hundred day moving average price is $1.96.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Read More
- Five stocks we like better than Nutriband
- Insider Trading – What You Need to Know
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Why Invest in 5G? How to Invest in 5G Stocks
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
